Jump to content

Vedaprofen

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 14:32, 22 June 2020 (Added FDA UNII). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Vedaprofen
Names
IUPAC name
2-(4-Cyclohexyl-1-naphthyl)propanoic acid
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.068.339 Edit this at Wikidata
UNII
  • InChI=1S/C19H22O2/c1-13(19(20)21)15-11-12-16(14-7-3-2-4-8-14)18-10-6-5-9-17(15)18/h5-6,9-14H,2-4,7-8H2,1H3,(H,20,21)
    Key: VZUGVMQFWFVFBX-UHFFFAOYSA-N
  • InChI=1/C19H22O2/c1-13(19(20)21)15-11-12-16(14-7-3-2-4-8-14)18-10-6-5-9-17(15)18/h5-6,9-14H,2-4,7-8H2,1H3,(H,20,21)
    Key: VZUGVMQFWFVFBX-UHFFFAOYAU
  • O=C(O)C(c2ccc(c1ccccc12)C3CCCCC3)C
Properties
C19H22O2
Molar mass 282.383 g·mol−1
Pharmacology
QM01AE90 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Vedaprofen is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the treatment of pain and inflammation due to musculoskeletal disorders in dogs and horses and for the treatment of pain due to horse colic.[1]

Synthesis

Vedaprofen synthesis: BE 870553  U.S. patent 4,218,473

References

  1. ^ "Specific Nonsteroidal Anti-inflammatory Drugs". Merck Veterinary Manual. Merck Sharp & Dohme Corp.